The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples

<div>Volcano plots for metabolic syndrome (MetS) (a) and BMI (b). The dashed line indicates the Bonferroni-adjusted significance threshold. Coefficients are interpreted as SD change in protein levels by 1SD change in MetS score and BMI, respectively. <i>R</i><sup>2</sup><sub>m</sub> is the proportion of variance explained by the included fixed factors.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples 

Figure 2 | The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples 